Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume 39, Issue 5, Pages 2065-2084
Publisher
Springer Science and Business Media LLC
Online
2022-03-14
DOI
10.1007/s12325-022-02098-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eosinophilic and non-eosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort
- (2021) Liam G. Heaney et al. CHEST
- Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
- (2021) John W. Upham et al. Journal of Allergy and Clinical Immunology-In Practice
- Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to Five Years
- (2021) Stephanie Korn et al. Journal of Allergy and Clinical Immunology-In Practice
- Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study
- (2021) Trung N Tran et al. Journal of Asthma and Allergy
- Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study
- (2021) Andrew Menzies-Gow et al. Lancet Respiratory Medicine
- Super-Responders to Severe Asthma Treatments: Defining a New Paradigm
- (2021) Hitasha Rupani et al. Journal of Allergy and Clinical Immunology-In Practice
- 2021 DORIS definition of remission in SLE: final recommendations from an international task force
- (2021) Ronald F van Vollenhoven et al. Lupus Science & Medicine
- Postbronchodilator lung function improvements with benralizumab for patients with severe asthma
- (2020) Sameer K. Mathur et al. ALLERGY
- Severe asthma: oral corticosteroid alternatives and the need for optimal referral pathways
- (2020) Didier Cataldo et al. JOURNAL OF ASTHMA
- Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure
- (2020) Kevin R. Murphy et al. Journal of Allergy and Clinical Immunology-In Practice
- Impact of comorbid conditions on asthmatic adults and children
- (2020) Alan Kaplan et al. npj Primary Care Respiratory Medicine
- Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
- (2020) David J Jackson et al. THORAX
- Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
- (2020) Tim W Harrison et al. Lancet Respiratory Medicine
- The Relationship of Asthma Biologics to Remission for Asthma
- (2020) Andrew Menzies-Gow et al. Journal of Allergy and Clinical Immunology-In Practice
- Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study
- (2020) Carey M. Suehs et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database
- (2019) Arnaud Bourdin et al. Journal of Allergy and Clinical Immunology-In Practice
- Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus
- (2019) Silvio Danese et al. DIGESTIVE DISEASES
- Phenotypes and endotypes of adult asthma: Moving toward precision medicine
- (2019) Ravdeep Kaur et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Different endotypes and phenotypes drive the heterogeneity in severe asthma
- (2019) P. Jane McDowell et al. ALLERGY
- Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management
- (2019) Eugene R Bleecker et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma
- (2019) Latifa Chachi et al. EUROPEAN RESPIRATORY JOURNAL
- ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
- (2019) Arnaud Bourdin et al. EUROPEAN RESPIRATORY JOURNAL
- Characterization of severe asthma worldwide: data from the International Severe Asthma Registry (ISAR)
- (2019) Wang Eileen et al. CHEST
- The relationship of airway structural changes to blood and bronchoalveolar lavage biomarkers, and lung function abnormalities in asthma
- (2019) Pawel Kozlik et al. CLINICAL AND EXPERIMENTAL ALLERGY
- An expert consensus framework for asthma remission as a treatment goal
- (2019) Andrew Menzies-Gow et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- ACG Clinical Guideline: Management of Crohn’s Disease in Adults
- (2018) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma
- (2018) Hector Ortega et al. Journal of Allergy and Clinical Immunology-In Practice
- “T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin
- (2018) Stelios Pavlidis et al. EUROPEAN RESPIRATORY JOURNAL
- Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use
- (2018) Diego Jose Maselli et al. Therapeutics and Clinical Risk Management
- Mortality: a neglected outcome in OCS-treated severe asthma
- (2017) Arnaud Bourdin et al. EUROPEAN RESPIRATORY JOURNAL
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Theo Vos et al. LANCET
- Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma
- (2017) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA
- (2017) Robert Y. Suruki et al. BMC Pulmonary Medicine
- Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma
- (2017) Robert S. Zeiger et al. Journal of Allergy and Clinical Immunology-In Practice
- Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
- (2016) Eugene R Bleecker et al. LANCET
- Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) J Mark FitzGerald et al. LANCET
- Reductions in eosinophil biomarkers by benralizumab in patients with asthma
- (2016) Tuyet-Hang Pham et al. RESPIRATORY MEDICINE
- Decreased physical activity in adults with bronchial asthma
- (2016) Alex J. van 't Hul et al. RESPIRATORY MEDICINE
- Utilization and Costs of Severe Uncontrolled Asthma in a Managed-Care Setting
- (2016) Robert S. Zeiger et al. Journal of Allergy and Clinical Immunology-In Practice
- Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses
- (2014) Donald P. Tashkin et al. JOURNAL OF ASTHMA
- Clinical Burden and Predictors of Asthma Exacerbations in Patients on Guideline-based Steps 4-6 Asthma Therapy in the TENOR Cohort
- (2014) William J. Calhoun et al. Journal of Allergy and Clinical Immunology-In Practice
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- Asthma outcomes: Pulmonary physiology
- (2012) Robert S. Tepper et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Review article: defining remission in ulcerative colitis
- (2011) S. P. L. Travis et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
- (2011) D. T. Felson et al. ANNALS OF THE RHEUMATIC DISEASES
- Remission of asthma: The next therapeutic frontier?
- (2011) John W. Upham et al. PHARMACOLOGY & THERAPEUTICS
- MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
- (2010) Roland Kolbeck et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search